| RCKT Stock | | | USD 14.39 0.19 1.34% |
Rocket Pharmaceuticals financial indicator trend analysis is much more than just breaking down Rocket Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rocket Pharmaceuticals is a good investment. Please check the relationship between Rocket Pharmaceuticals Non Operating Income Net Other and its Income Tax Expense accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
For more information on how to buy Rocket Stock please use our
How to Invest in Rocket Pharmaceuticals guide.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Rocket Pharmaceuticals Non Operating Income Net Other account and
Income Tax Expense. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Rocket Pharmaceuticals' Non Operating Income Net Other and Income Tax Expense is -0.29. Overlapping area represents the amount of variation of Non Operating Income Net Other that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Rocket Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Rocket Pharmaceuticals' Non Operating Income Net Other and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Operating Income Net Other of Rocket Pharmaceuticals are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Non Operating Income Net Other i.e., Rocket Pharmaceuticals' Non Operating Income Net Other and Income Tax Expense go up and down completely randomly.
Correlation Coefficient | -0.29 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Most indicators from Rocket Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rocket Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
For more information on how to buy Rocket Stock please use our
How to Invest in Rocket Pharmaceuticals guide.At this time, Rocket Pharmaceuticals'
Selling General Administrative is comparatively stable compared to the past year.
Enterprise Value is likely to gain to about 2.6
B in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 203.6
M in 2024.
When running Rocket Pharmaceuticals' price analysis, check to
measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.